News

The collaboration will optimise the manufacture of AAV vectors to support gene therapy and regenerative medicine.

New drug delivery and bioavailability technology driving growth globally.

The GDC will centralize, standardize and make accessible data from NCI programs such as The Cancer Genome Atlas (TCGA) and its pediatric equivalent, to Generate Effective Treatments.

Company has announced collaboration with MSD to invest in and operate a large-scale microbial-biologics facility for supply of active pharmaceutical ingredient (API) to its customers.

IMAB362 nearly doubles survival in patients with the highest levels of Claudin18.2 to develop high target immunotherapy against cancer.

Research shows that the human protein IFITM3 blocks Zika virus replication and prevents cell death.

Cells have an alternative plan when energy is needed in the cell nucleus.

Lab Innovations 2016 returns to the NEC, Birmingham, for its fifth edition. The show, which has established itself as the UK’s only event dedicated to laboratory professionals, will take place on 2 & 3 November 2016.

Part of the National Cancer Moonshot, the GDC will centralize and standardize accessible data.

Toxins extracted from ornamental baboon tarantula may be used as tools to study disorders ranging from irritable bowel syndrome to epilepsy.